Home » Oracle Buying Drug Trials Software Maker for $685 Million
Oracle Buying Drug Trials Software Maker for $685 Million
Oracle announced plans to buy Phase Forward, which develops software for drug
manufacturers, for about US $685 million. The deal is expected to close mid-year.
Computerworld
Computerworld
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May